文献
J-GLOBAL ID:201202217711501335
整理番号:12A1192289
大腸がん患者におけるKRAS codon61,KRAS codon146,BRAF,NRAS,PIK3CA変異の臨床的意義
Clinical outcome of cetuximab for metastatic colorectal cancer patients harboring KRAS codon61, KRAS codon146, BRAF, NRAS or PIK3CA mutations
著者 (11件):
YAMAZAKI Kentaro
(Shizuoka Cancer Center)
,
BANDO Hideaki
(National Cancer Center Hospital East)
,
SHINOZAKI Eiji
(Japanese Foundation for Cancer Res.)
,
NISHINA Tomohiro
(Shikoku Cancer Center)
,
KADOWAKI Shigenori
(Saitama Cancer Center)
,
YUKI Satoshi
(Hokkaido Univ. Graduate School of Medicine)
,
KAJIURA Shinya
(Univ. Toyama)
,
TSUCHIHARA Katsuya
(National Cancer Center Hospital East)
,
FUJII Satoshi
(National Cancer Center Hospital East)
,
YAMANAKA Takeharu
(National Cancer Center Hospital East)
,
YOSHINO Takayuki
(National Cancer Center Hospital East)
資料名:
日本臨床腫瘍学会学術集会プログラム・抄録集
(Abstracts. Annual Meeting of Japanese Society of Medical Oncology)
巻:
10th
ページ:
167-168
発行年:
2012年
JST資料番号:
L7804A
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)